Patent Assignment
Reel/Frame 074145/0450
Release of Security Interest Reel 066839, Frame 0679
Recorded: 2025-12-31
Pages: 19
Assignor
LSP 6 HOLDING C.V., AS COLLATERAL AGENT
Executed: 2025-12-31
Assignee
VISUS THERAPEUTICS, INC.
2 NICKERSON ST., STE. 101, SEATTLE, WASHINGTON, 98109
Covered Properties
(35)
Preparations and Methods for Ameliorating or Reducing Presbyopia
Preparations and Methods for Ameliorating or Reducing Presbyopia
Using Parasympathomimetic Drugs Alone or, in Combination with One or More Alpha Agonists in Pseudophakic Patients, to Create Multi-Focality
Application:
62/859,678 →
Using Parasympathomimetic Drugs Alone or, in Combination with One or More Alpha Agonists in Pseudophakic Patients, to Create Multi-Focality
Application:
62/913,794 →
Using Parasympathomimetic Drugs Alone or, in Combination with One or More Alpha Agonists in Pseudophakic Patients, to Create Multi-Focality
Application:
62/963,891 →
Using Parasympathomimetic Drugs Alone or, in Combination with One or More Alpha Agonists in Pseudophakic Patients, to Create Multi-Focality
Application:
62/970,155 →
Using Parasympathomimetic Drugs Alone or, in Combination with One or More Alpha Agonists in Pseudophakic Patients, to Create Multi-Focality
Application:
17/618,152 →
Publication:
US 2022/0175734
Using Parasympathomimetic Drugs Alone or, in Combination with One or More Alpha Agonists in Pseudophakic Patients, to Create Multi-Focality
Application:
18/184,447 →
Publication:
US 2023/0210821
Carabachol-Bromonidine Formulation to Enhance Anti-Presbyopia Effects
Application:
62/859,684 →
Carabachol-Bromonidine Formulation to Enhance Anti-Presbyopia Effects
Application:
62/913,793 →
Carabachol-Bromonidine Formulation to Enhance Antipresbyopia Effects
Application:
62/963,932 →
Carabachol-Bromonidine Formulation to Enhance Antipresbyopia Effects
Application:
62/970,157 →
Carbachol-Brimonidine Formulation to Enhance Anti-Presbyopia Effects
Application:
17/618,157 →
Publication:
US 2022/0257593
Degradant Compound in a Medicament
Application:
18/250,921 →
Publication:
US 2023/0390284
Degradant Compound in a Medicament
Application:
18/535,520 →
Publication:
US 2024/0100046
Degradant Compound in a Medicament
Application:
63/162,367 →
Degradant Compound in a Medicament
Application:
63/257,024 →
Carbachol Formulations to Enhance Anti-Presbyopia Effects
Application:
63/278,081 →
Formulations Comprising Carbachol and Brimonidine to Enhance Anti-Presbyopia Effects
Synthesis of 2-(Carbamoyloxy)-N,N,N-Trimethylethan-1-Aminium Salts
Application:
63/508,601 →
Compounds and Formulations for Treating Ophthalmic Diseases
Application:
18/043,146 →
Publication:
US 2023/0322672
Histatin Combinations and Methods for Inhibiting Cell Loss
Application:
63/224,982 →
Histatin Combinations and Methods for Inhibiting Cell Loss
Application:
63/238,061 →
Histatin Combinations and Methods for Treating or Inhibiting Cell Loss
Application:
63/252,468 →
Use of Peptides for Promoting Wound Healing
Use of Peptides for Promoting Wound Healing
Application:
13/827,384 →
Publication:
US 2013/0288964
Use of Peptides for Promoting Wound Healing
Use of Peptides for Promoting Wound Healing
Use of Peptides for Promoting Wound Healing
Application:
14/735,450 →
Publication:
US 2015/0273014
Histatin for Corneal Wound Healing and Ocular Surface Disease
Application:
61/648,845 →
Histatin for Corneal Wound Healing and Ocular Surface Disease
Application:
13/788,761 →
Publication:
US 2013/0310326
Histatin for Corneal Wound Healing and Ocular Surface Disease
Application:
13/788,803 →
Publication:
US 2013/0310327
Histatin for Corneal Wound Healing and Ocular Surface Disease
Histatin for Corneal Wound Healing and Ocular Surface Disease
Application:
16/525,367 →
Publication:
US 2019/0343922
Histatin for Corneal Wound Healing and Ocular Surface Disease
Application:
18/061,699 →
Publication:
US 2023/0277620
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 5, 2013
From: KAUFMAN, HERBERT F.
To: HEK DEVELOPMENT, LLC
Reel/Frame 029753/0980 →
Assignment of Assignor's Interest
Feb 5, 2013
From: KAUFMAN, HERBERT F.
To: HEK DEVELOPMENT, LLC
Reel/Frame 029753/0804 →
Assignment of Assignor's Interest
Nov 10, 2014
From: VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 034132/0300 →
Assignment of Assignor's Interest
Jun 11, 2015
From: VEERMAN, ENGELMUNDUS CORNELIS IGNATIUS; VAN NIEUW AMERONGEN, ARIE; BOLSCHER, JOHANNES GERHARDUS MARIA; VAN'T HOF, WILLEM
To: VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG
Reel/Frame 035890/0455 →
Assignment of Assignor's Interest
Jun 11, 2015
From: VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 035824/0203 →
Security Interest
Dec 20, 2018
From: RAPID PATHOGEN SCREENING, INC.; RPS DIAGNOSTICS, INC.
To: LUMOS DIAGNOSTICS HOLDINGS PTY LTD
Reel/Frame 047834/0030 →
Assignment of Assignor's Interest
May 22, 2020
From: HEK DEVELOPMENT, LLC
To: VISUS THERAPEUTICS, INC.
Reel/Frame 052733/0106 →
Assignment of Assignor's Interest
May 22, 2020
From: SAMBURSKY, ROBERT P.; KAUFMAN, HERBERT E.
To: VISUS THERAPEUTICS, INC.
Reel/Frame 052732/0776 →
Assignment of Assignor's Interest
May 22, 2020
From: RAPID PATHOGEN SCREENING, INC.
To: VISUS THERAPEUTICS, INC.
Reel/Frame 052732/0296 →
Assignment of Assignor's Interest
May 22, 2020
From: HEK DEVELOPMENT, LLC.
To: VISUS THERAPEUTICS, INC.
Reel/Frame 052733/0128 →
Assignment of Assignor's Interest
Jun 12, 2020
From: SAMBURSKY, ROBERT P; KAUFMAN, HERBERT E
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 052933/0248 →
Assignment of Assignor's Interest
Jul 2, 2020
From: RAPID PATHOGEN SCREENING, INC.
To: VISUS THERAPEUTICS, INC.
Reel/Frame 053107/0732 →
Assignment of Assignor's Interest
Jan 22, 2021
From: SAMBURSKY, ROBERT P
To: VISUS THERAPEUTICS, INC.
Reel/Frame 055002/0981 →
Assignment of Assignor's Interest
Jan 22, 2021
From: SAMBURSKY, ROBERT P
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 055002/0367 →
Assignment of Assignor's Interest
Jan 22, 2021
From: KAUFMAN, HERBERT E
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 055002/0169 →
Assignment of Assignor's Interest
Jan 22, 2021
From: KAUFMAN, HERBERT E
To: VISUS THERAPEUTICS, INC.
Reel/Frame 055002/0731 →
Assignment of Assignor's Interest
Jan 22, 2021
From: RAPID PATHOGEN SCREENING, INC.
To: VISUS THERAPEUTICS, INC.
Reel/Frame 055002/0555 →
Assignment of Assignor's Interest
Oct 11, 2021
From: SCHIFFMAN, RHETT M.
To: VISUS THERAPEUTICS, INC.
Reel/Frame 057755/0077 →
Assignment of Assignor's Interest
Oct 11, 2021
From: BURKE, JAMES ALBERT; SCHIFFMAN, RHETT MEAD
To: VISUS THERAPEUTICS, INC.
Reel/Frame 057754/0900 →
Assignment of Assignor's Interest
Oct 11, 2021
From: BURKE, JAMES ALBERT; SCHIFFMAN, RHETT MEAD
To: VISUS THERAPEUTICS, INC.
Reel/Frame 057754/0974 →
Assignment of Assignor's Interest
Nov 2, 2021
From: PHARMASSIST CMC CONSULTING, LLC
To: VISUS THERAPEUTICS, INC.
Reel/Frame 057995/0083 →
Assignment of Assignor's Interest
Nov 2, 2021
From: SCHIFFMAN, RHETT MEAD
To: VISUS THERAPEUTICS, INC.
Reel/Frame 057995/0026 →
Assignment of Assignor's Interest
Nov 2, 2021
From: FIRESTONE, BRUCE ALAN
To: PHARMASSIST CMC CONSULTING, LLC
Reel/Frame 057995/0072 →
Assignment of Assignor's Interest
Nov 2, 2021
From: BURKE, JAMES ALBERT; SCHIFFMAN, RHETT MEAD
To: VISUS THERAPEUTICS, INC.
Reel/Frame 057996/0473 →
Corrective Assignment to Correct the the Correct Name of the Inventor Is Herbert E. Kaufman Previously Recorded at Reel: 029753 Frame: 0804. Assignor(S) Hereby Confirms the Assignment.
Dec 29, 2021
From: KAUFMAN, HERBERT E.
To: HEK DEVELOPMENT, LLC
Reel/Frame 058570/0267 →